February 28, 2018 / 9:39 PM / 4 months ago

BRIEF-Portola Pharmaceuticals Q4 Loss Per Share $1.41

Feb 28 (Reuters) - Portola Pharmaceuticals Inc:

* PORTOLA PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

* Q4 LOSS PER SHARE $1.41

* FOR FISCAL YEAR 2018, PORTOLA EXPECTS TOTAL GAAP OPERATING EXPENSES TO BE BETWEEN $390 MILLION AND $430 MILLION

* QTRLY COLLABORATION AND LICENSE REVENUE $9.8 MILLION VERSUS $13.7 MILLION

* Q4 EARNINGS PER SHARE VIEW $-1.46 -- THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below